Welcome to our dedicated page for Nordson news (Ticker: NDSN), a resource for investors and traders seeking the latest updates and insights on Nordson stock.
Nordson Corporation manufactures precision technology equipment and systems used to dispense, apply, test, inspect, and control adhesives, coatings, sealants, fluids, and other materials. Its recurring updates cover quarterly earnings, margins, guidance, dividends, and demand across consumer non-durable, medical, electronics, semiconductor, packaging, and industrial end markets.
Company news also includes Nordson EFD product and trade-show activity for precision fluid dispensing, automated assembly, and medical device manufacturing applications. Segment commentary commonly references Industrial Precision Solutions, Medical and Fluid Solutions, and Advanced Technology Solutions, along with the company’s direct sales model and applications expertise.
Nordson (Nasdaq: NDSN) reported a record fiscal Q1 with $669.5M sales (up 9% YoY) and GAAP diluted EPS of $2.38. Adjusted EPS was a first-quarter record of $2.37 (up 15% YoY). EBITDA was a Q1 record of $203M (30% of sales). Backlog rose ~4%, and management increased full-year guidance to $2.86–$2.98B in sales and adjusted EPS of $11.00–$11.60.
Organic growth was broad-based across segments, led by a 23% increase in Advanced Technology Solutions. Results included a non-cash gain on a minority investment and favorable currency translation.
Nordson (Nasdaq: NDSN) will release first quarter fiscal 2026 earnings on February 18, 2026 after market close and will host a quarterly webcast on February 19, 2026 at 8:30 AM ET.
Investors can listen live via the provided webcast link and can access a replay on Nordson's investor website. The company is a precision technology provider serving medical, electronics, consumer non-durable and industrial end markets, with operations in over 35 countries.
Nordson EFD (NASDAQ: NDSN) will spotlight medical assembly automation at MD&M West, Anaheim Convention Center, Feb 3–5, 2026, in Booth 2915. Live demonstrations will show PROX 3-axis and PROPlus 4-axis automated fluid dispensing systems, PICO Nexus controllers with PICO XP jet valves, and Optimum dispensing components for medical device prototyping and assembly.
Company experts will present "Cracking the Code on Assembly Automation" (Session ID: MSC01) on Feb 3, 2026, 10:15–11:00 AM, Room 206AB, covering industrializing fluid assembly and a customer case from prototype to high-volume production.
Nordson (Nasdaq: NDSN) reported record fiscal 2025 results and provided fiscal 2026 guidance. Q4 sales were $752M (up 1%); Q4 diluted EPS $2.69 and adjusted EPS $3.03 (up 9%).
Full-year sales were a record $2.8B (up 4%); adjusted EPS were a record $10.24 (up 5%); EBITDA was $900M (32% of sales). Free cash flow was a record $661M (136% conversion).
Fiscal 2026 guidance: sales $2,830–2,950M and adjusted EPS $10.80–11.50; backlog ~$600M (up 5%).
Nordson (Nasdaq: NDSN) announced a fiscal 2026 first quarter cash dividend of $0.82 per common share. The dividend is payable on January 2, 2026 to shareholders of record at the close of business on December 17, 2025. The declared amount equals the $0.82 dividend paid in the fourth quarter of fiscal 2025, reflecting a maintained quarterly payout.
The company describes itself as a precision technology provider serving diverse end markets including medical, electronics, consumer non-durable, and industrial, with operations in over 35 countries.
Nordson EFD (NASDAQ: NDSN) will present four live “Mastering Micron-Level Assembly” demonstrations at Compamed 2025 in Düsseldorf, November 17–20, 2025, at Stand D01/Hall 8a.
The demonstrations use a vision-guided PROPlus robotic fluid dispensing system to show needle bonding, micron-level deposition on a Cardiac Care Card, UV dry cure for blood glucose test strips, and assembly of a continuous glucose monitoring (CGM) protective sleeve. A video podcast appearance by Michael Gavican on Trade Talk Today is scheduled for November 19 at 3:00pm.
Nordson EFD emphasizes precision fluid dispensing for medical device assembly and consultant support from prototype to finished device.
Nordson Corporation (Nasdaq: NDSN) will release fourth quarter and fiscal year 2025 earnings on December 10, 2025 after market close and will host a webcast on December 11, 2025 at 8:30 AM ET.
Investors can listen live at https://events.q4inc.com/attendee/211633413 and access a replay on Nordson's investor website if they cannot join the live session. The company describes itself as a precision technology provider serving consumer non-durable, medical, electronics and industrial end markets, with operations in over 35 countries.
Nordson (Nasdaq: NDSN) published its 2025 Corporate Responsibility Update on October 21, 2025, outlining progress on sustainability, employee programs, safety and community engagement.
Key highlights include development programs for all career stages with new eLearning tracks for NBS Next, enhanced U.S. parental leave and mental health resources, improved safety incident rates via the Journey to Zero initiative, ongoing energy efficiency upgrades, and more than $11 million in global charitable contributions. The company also strengthened its Suppliers’ Code of Conduct and reported a more diverse Board of Directors. The update is available on Nordson’s Corporate Responsibility and Sustainability webpage.
Nordson EFD (NASDAQ: NDSN) has successfully completed two summer internships for Rhode Island high school students through its partnership with PrepareRI, a state-wide initiative focused on preparing youth for in-demand jobs. The program, now in its ninth year, placed two female students at Nordson's East Providence facility, where they gained hands-on experience in manufacturing and engineering.
The interns participated in a structured 6-week program that included mentorship from Nordson professionals, job shadowing opportunities with technicians and machine operators, and practical assignments in quality documentation and work procedures. The initiative is part of Nordson EFD's ongoing commitment to fostering STEM education and developing a skilled workforce for their precision dispensing systems manufacturing operations.
Nordson Corporation (NASDAQ: NDSN) has completed the divestiture of select product lines from its medical contract manufacturing business to Quasar Medical. The strategic move aims to sharpen the company's focus on higher-value growth opportunities within its $800 million medical and fluid solutions segment.
The company will concentrate on its proprietary medical components portfolio, including balloons, cannula, nitinol devices, and recently acquired Atrion products. The divestiture is expected to enable a more focused approach to Nordson's core medical technology business while ensuring a smooth transition for existing contract manufacturing customers under Quasar's leadership.